Evidence map›Paper›PMID 23665182›Full record

ArticleJournal of hepatology2013

Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.

Vishwadeep Ahluwalia, James B Wade, Leroy Thacker, Kenneth A Kraft, Richard K Sterling, R Todd Stravitz, Michael Fuchs, Iliana Bouneva, Puneet Puri, Velimir Luketic and 4 more

Abstract read
In one paragraph

Article in Journal of hepatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores?Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2017
    Article
  20. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Vishwadeep AhluwaliaRadiology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA.
James B Wade
Leroy Thacker
Kenneth A Kraft
Richard K Sterling
R Todd Stravitz
Michael Fuchs
Iliana Bouneva
Puneet Puri
Velimir Luketic
Arun J Sanyal
Hochong Gilles
Douglas M Heuman
Jasmohan S Bajaj
Hunter Holmes McGuire VA Medical Center · USVirginia Commonwealth University · US

Funding

Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2015
$12.5M
Spectrum of Neuro-Cognitive Impairment in CirrhosisR01DK087913 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2011 to 2015
$2.0M
Hepatic Encephalopathy in Alcoholic Cirrhosis: A Systems Biology ApproachR01AA020203 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2010 to 2012
$1.0M
Probiotic Yogurt for the Treatment of Minimal Hepatic EncephalopathyU01AT004428 · NCCIH · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2009 to 2011
$848k
NCATS NIH HHS UL1 TR000058NCATS NIH HHS UL1TR00058NCCIH NIH HHS U01 AT004428NCCIH NIH HHS U01AT004428NIAAA NIH HHS R01 AA020203NIAAA NIH HHS R01AA020203NIDDK NIH HHS R01 DK087913NIDDK NIH HHS R01DK087913
6 · The paper itself

Abstract

BACKGROUND &

aimsHyponatremia (HN) and hepatic encephalopathy (HE) together can impair health-related quality of life (HRQOL) and cognition in cirrhosis. We aimed at studying the effect of hyponatremia on cognition, HRQOL, and brain MR spectroscopy (MRS) independent of HE.

methodsFour cirrhotic groups (no HE/HN, HE alone, HN alone (sodium <130 mEq/L), HE+HN) underwent cognitive testing, HRQOL using Sickness Impact Profile (SIP: higher score is worse; has psychosocial and physical sub-scores) and brain MRS (myoinositol (mI) and glutamate+glutamine (Glx)), which were compared across groups. A subset underwent HRQOL testing before/after diuretic withdrawal.

results82 cirrhotics (30 no HE/HN, 25 HE, 17 HE+HN, and 10 HN, MELD 12, 63% hepatitis C) were included. Cirrhotics with HN alone and without HE/HN had better cognition compared to HE groups (median abnormal tests no-HE/HN: 3, HN: 3.5, HE: 6.5, HE+HN: 7, p=0.008). Despite better cognition, HN only patients had worse HRQOL in total and psychosocial SIP while both HN groups (with/without HE) had a significantly worse physical SIP (p<0.0001, all comparisons). Brain MRS showed the lowest Glx in HN and the highest in HE groups (p<0.02). mI levels were comparably decreased in the three affected (HE, HE+HN, and HN) groups compared to no HE/HN and were associated with poor HRQOL. Six HE+HN cirrhotics underwent diuretic withdrawal which improved serum sodium and total/psychosocial SIP scores.

conclusionsHyponatremic cirrhotics without HE have poor HRQOL despite better cognition than those with concomitant HE. Glx levels were lowest in HN without HE but mI was similar across affected groups. HRQOL improved after diuretic withdrawal. Hyponatremia has a complex, non-linear relationship with brain Glx and mI, cognition and HRQOL.

Indexed as

BrainCognitionCognition DisordersDiureticsFemaleGlutamic AcidGlutamineHepatic EncephalopathyHumansHyponatremiaInositolLiver CirrhosisMagnetic Resonance SpectroscopyMaleMiddle AgedQuality of LifeDiureticsGlutamic AcidGlutamineInositolACCanterior cingulate cortexBDTblock design testCHESSChocholineclinical hepatic encephalopathy staging scaleCognitive functionCrcreatinedigit symbol testDSTglutamate+glutamineGlxHEhealth-related quality of lifeHE+HNhepatic encephalopathyHepatic encephalopathyhepatic encephalopathy and hyponatremiaHNHRQOLhyponatremiaHyponatremiaICTinhibitory control testline tracing test time/errorsLTTt/emagnetic resonance imagingmagnetic resonance spectroscopyMagnetic resonance spectroscopyMELDmImini-mental status examinationMMSEModel for End-Stage Liver DiseaseMRIMRSmyoinositolNNCT-A/Bneither HE nor hyponatremianumber connection tests A/Boccipital gray matterOGMPHESpoint resolved spectroscopyPRESSpsychometric hepatic encephalopathy scoreright parietal white matterRPWMSDTserial dotting testsickness impact profileSickness Impact ProfileSIPTIPStransjugular intra-hepatic porto-systemic shuntingVOIvoxel of interest

Identifiers

PMID23665182
PMCPMC3748234
OpenAlexW2054175399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.